Fresenius (NYSE:FMS) recently announced that its Fresenius Medical Care North America (FMCNA) business has launched a connected health platform called TheHub.
TheHub includes three integrated applications meant to enable people on dialysis, their care teams, and health providers to better collaborate. Fresenius officials see the system enhancing remote monitoring for people on home dialysis.
The Trump administration has been pushing to move more dialysis out of brick-and-mortar clinics — a major source of revenue for Fresenius — and into people’s homes.
“The simple and streamlined experience supports our effort to advance and accelerate the adoption of home therapies while ensuring our patients stay well connected to their care teams,” said Jeff Burbank, chief strategy and transformation officer for Fresenius Medical Care North America.
TheHub integrates three applications that Fresenius has already rolled out:
- PatientHub allows patients to submit daily treatment data, access lab results and medications, message their care team, order supplies, and seek support from others on dialysis.
- CareTeamHub enables home therapy nurses to better provide personalized daily monitoring and clinical decision support to home dialysis patients.
- ProviderHub offers physicians and advanced practitioners convenient, real-time access to medical records.
To date, more than 15,000 patients have submitted more than 2 million flowsheets and 17,000 supply orders over PatientHub. More than 3,000 nurses on CareTeamHub have evaluated more htan 1 million daily treatment data records. And more than 2,000 providers have used the ProviderHub.